Home/Filings/4/0001213900-23-029888
4//SEC Filing

Lis William 4

Accession 0001213900-23-029888

CIK 0001788028other

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 4:14 PM ET

Size

4.9 KB

Accession

0001213900-23-029888

Insider Transaction Report

Form 4
Period: 2023-04-13
Lis William
DirectorChief Executive Officer
Transactions
  • Sale

    Voting Common Stock

    2023-04-13$1.44/sh8,500$12,24061,486 total
Footnotes (1)
  • [F1]These shares were sold by the Reporting Person solely in order to satisfy certain tax obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001574558

Filing Metadata

Form type
4
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:14 PM ET
Size
4.9 KB